5329152026-11-042026-11-045329152026-11-045329152026-11-04

ChangeInManagementDomain1

5329152026-11-042026-11-04

ChangeInManagementDomain1

5329152026-11-04

ChangeInManagementDomain2

5329152026-11-042026-11-04

ChangeInManagementDomain2

5329152026-11-04

ChangeInManagementDomain3

5329152026-11-042026-11-04

ChangeInManagementDomain3

5329152026-11-04

ChangeInManagementDomain4

5329152026-11-042026-11-04

ChangeInManagementDomain4

xbrli:pure

RELIGARE

RELIGARE ENTERPRISES LIMITED

532915

NOTLISTED

INE621H01010

true

Listed Entity (self)

false

2026-11-03

12:20:00

2026-11-04

Appointment

Director

Non - Executive Non -Independent Director

Not Applicable

Mr.

Anand Chand Burman

2026-11-03

Dr. Anand C. Burman is the Chairman Emeritus of Dabur lndia, one of India’s leading consumer goods companies with presence in over 120 countries across the globe. Dr. Burman is a trained pharmacist and is widely recognized for his interests in Research & Development that has helped him earn over 40 patents against his name. Dr. Burman has particular interests in the areas of R&D in Pharmaceutical Sciences as well as Biotechnology and Technology issues. His education was both multidisciplinary and international. He completed his high school education from St. Paul's School in Darjeeling, India and followed it with a B.Sc. in Chemistry from the University of Wisconsin and M. Sc. in Chemistry from the University of Kansas. His Doctorate was in the area of Pharmaceutical Chemistry from the University of Kansas in 1980. Further, Dr. Burman has more than 35 years of experience in the Non-Banking Financial Company (NBFC) sector. He is a Promoter and Director of Puran Associates Private Limited, NBFC, and has been associated with the company since October 1990. Over the years, he has been actively involved in guiding the company's financial and investment activities, including strategic decision-making, evaluation of investment opportunities, financial management, and ensuring compliance with applicable statutory and regulatory requirements. Dr. Burman is also a Promoter and Director of Milky Investment and Trading Company, NBFC and has been serving on its Board since April 2006. In this role, he has been involved in overseeing the company's investment and financial operations and participating in key policy and governance decisions. Dr. Burman is a member of the fifth generation of Dabur group's founder family and took charge as chairman in 2007 after holding the post of vice-chairman and having been associated with the company in various other roles. His interests in R&D closely align with Dabur's focus on developing products that offer holistic wellness, and spearheaded Dabur's transformation from an Ayurvedic medicines maker to becoming India's 4th largest FMCG (Fast Moving Consumer Goods) player. He also serves as Director on the Board of Dabur Research Foundation, Dabur (UK) Limited, H&B Stores Limited, among others. He stepped down as the Chairman of Dabur India Ltd in 2019. Other than the Dabur Group Companies, he is a member of the Advisory Board of the Institute for Advancing Medical Innovation under the University of Kansas, USA. Dr. Burman is the recipient of numerous awards and honours, including the Ernst & Young Entrepreneur of the Year award in 2011.

Father of Mr. Aditya Chand Burman

true

false

Appointment

Director

Non - Executive Non -Independent Director

Not Applicable

Mr.

Aditya Chand Burman

2026-11-03

A 6th generation member of the Burman family, Mr. Aditya Burman is a Director on the board of Dabur India Ltd, one of lndia’s largest and most diverse consumer goods maker. A Chemistry Graduate from the University of Kansas (US), Aditya is part of the team providing strategic direction to Dabur's businesses spread across 120 countries. Aditya began his career as an intern at Dabur Pharma, a family-owned Oncology focused Pharmaceutical firm under his father Dr. Anand C. Burman. Fueled with grit and perseverance, Aditya worked towards expanding the company's footprint in the overseas markets and was soon in charge of its Sales and Marketing in Latin America. Under his stewardship, Dabur Pharma emerged as a leading research-driven pharmaceutical firm with a global presence. The company was subsequently sold to Fresenius Kaki in 2008. Further, Mr. Aditya Chand Burman, has around 20 years over all experience, out of which over 15 years rich experience is in the Non-Banking Financial Company (NBFC) sector through his association with various NBFC entities as a director. He had served as a Director in Milky Investment and Trading Company (MITC), registered with RBI as NBFC (ICC- Middle Layer) having registration number B-14. 03145 vide certificate of registration dated 07. 04. 2008, from September 2018 to June 2025. During this period, he was involved in participating in board-level discussions and overseeing the investment and financial activities of the MITC. He is also associated with Puran Associates Private Limited, (PAPL), a NBFC registered with RBI as NBFC (ICC- Middle layer), having registration number 14.00393 vide certificate of registration dated 1 1. 03. 1998 as a Director. Wherein they have gained exposure to the functioning of NBFCs, including investment activities, corporate governance, and compliance with applicable regulatory requirements. Born in January 1980, Aditya lives in Delhi and has also been supporting several charities in the Health Care and Health Awareness space. He has also been actively involved with agencies in supporting children suffering from Cancer.

Son of Dr. Anand Chand Burman

true

false

Appointment

Director

Non - Executive Non -Independent Director

Not Applicable

Mr.

Mohit Burman

2026-11-03

Mr. Mohit Burman is the Chairman of Dabur India Limited, having its global presence in over 120 countries. He has to his credit acquisition of Balsara Hygiene and Home Care in 2005 enhancing Dabur's product portfolio and then Femcare Pharma Limited thereby expanding Dabur's skincare segment. He has been instrumental in expanding the group's financial services business into Asset Management and Life Insurance by setting up insurance Company AVIVA Life Insurance Company India Ltd. He has also played a pivotal role in establishing Universal Sompo General Insurance, a consortium with Allahabad Bank, Indian Overseas Bank, Karnataka Bank, and Sompo Japan. Further he has around 25 years of experience in the Non-Banking Financial Company (NBFC) sector. He has been associated with NBFC business activities since May 2001 and is serving as a Promoter and Director in NBFC entities. In his role as Promoter and Director, he has been involved in overseeing the investment and financial activities of the companies, participating in important business decisions, and guiding the overall financial and investment strategy. Through his continuous association with NBFC operations for nearly three decades, he has gained substantial experience in financial services, investment management, and the regulatory framework governing NBFCs. Further, he has led the Burman family's acquisition of a majority stake in Eveready Industries India Ltd., India's leading dry cell battery manufacturer and Punjab Tractors Limited which was later sold to Mahindra & Mahindra after a successful turnaround. His Entrepreneurial Ventures include - H&B Stores Ltd. (NewU)- A beauty retail chain with over 90 stores across India, Burman Hospitality- brought Taco Bell to India, operating over 100 outlets. He is a seasoned entrepreneur and is associated in various capacities with different sports franchise teams in India. He is actively involved in various welfare activities aimed at improving the quality of life for underprivileged sections of society. He also supports elephant conservation initiatives through the Worldwide Fund for Nature-India.

Nephew of Dr. Anand Chand Burman and Cousin Brother of Mr. Aditya Chand Burman

true

false

Appointment

Director

Non - Executive Non -Independent Director

Not Applicable

Mr.

Jimeet Vipul Modi

2026-11-03

Mr. Jimeet Modi is the Founder and Group CEO of SAMCO Group, which operates businesses across securities broking, wealth management, and asset management. He is also the Founder Director and Chairman of the Investment Committee, at SAMCO Asset Management. A qualified Chartered Accountant with an All India Rank 9 and a qualified Chartered Financial Analyst (CFA) from the CFA Institute, USA, Mr. Modi has been instrumental in driving the Group's strategic direction, technology led platforms, and quantitative investment frameworks. At SAMCO Asset Management, he oversees the development of model-driven investment strategies and portfolio frameworks. His work integrates principles of quantitative finance, risk management, and systematic investing to build disciplined, process-oriented investment solutions. In addition to his roles at SAMCO, he is also responsible for the management and oversight of the Modi Family Office, which focuses on long-term investments across public and private markets. He possesses a broad range of expertise spanning securities laws, contract laws, compliance, investments, financial analysis, accounting, taxation, management, and technology. His multidisciplinary experience enables him to bring a comprehensive perspective to corporate governance, financial strategy, and business operations.

Nil

true

false